PROSTATE-CANCER AWARENESS WEEK, 1992 - A SUMMARY OF KEY FINDINGS

Citation
E. Deantoni et al., PROSTATE-CANCER AWARENESS WEEK, 1992 - A SUMMARY OF KEY FINDINGS, Clinical and investigative medicine, 16(6), 1993, pp. 448-457
Citations number
25
Categorie Soggetti
Medicine, Research & Experimental
ISSN journal
0147958X
Volume
16
Issue
6
Year of publication
1993
Pages
448 - 457
Database
ISI
SICI code
0147-958X(1993)16:6<448:PAW1-A>2.0.ZU;2-3
Abstract
Prostate Cancer Awareness Week was begun in 1989 to investigate whethe r men could be recruited to participate in free prostate cancer screen ing. Initially designed to raise public awareness of ''the ignored mal e disease'', it has become the largest single cancer screening program in the United States. In 1992, more than 500,000 men were examined by digital rectal examination (DRE) and more than half of these also by measuring prostate-specific antigen (PSA). Although the populations ex amined have been generally better educated than the national average, predominantly white, and typically (>40%) experiencing some symptom of prostate disease, adherence to annual prostate examinations remains l ow among successive cohorts of participants. Prostate cancers detected through this program exhibit a more favorable stage distribution than the national average. From 1989 through 1992, many cancers were detec ted by using the effective combination of DRE and PSA testing, which r esulted in more stage A disease being diagnosed and fewer stage B, C, and D tumors. Data from 1992 suggest that increasing sophistication is possible with PSA test results, and age-specific PSA reference ranges have been developed.